BD to sell surgical devices business, 3 manufacturing facilities

Becton Dickinson plans to sell its surgical devices business and three manufacturing plants as part of a divestment planned for the end of 2023. 

Advertisement

Steris, an Ireland-based medical devices company, will buy Becton Dickinson’s surgical products business for $540 million, which includes manufacturing sites in St. Louis, Cleveland and Tuttlingen, Germany, according to a June 20 news release.

“Divesting the platform advances [… the company’s] 2025 strategy and is an important step in simplifying BD’s product portfolio and manufacturing network,” the release said.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.